Life Sciences —
If you’ve been following the story of Nobel Laureate James Watson on this blog, and haven’t heard the latest news, the saga has taken its final twist. The Cold Spring Harbor Board of Trustees, who suspended Watson following the crazy public comments he made recently in London, have accepted his resignation with immediate effect. In [...]
The James Watson story has moved on since I wrote about it a few days ago (see Is James Watson Senile, Or Just Stupid?). Watson’s employer, Cold Spring Harbor, in New York has suspended him from his position as Chancellor with immediate effect, pending investigations into his behaviour. This is the right [...]
He’s a Nobel laureate. He claims to have had the idea that led to the discovery of the three-dimensional structure of DNA; one of the most important scientific discoveries of the last century. However, he’s now 79 years old, and the evidence suggests that, whatever level of intelligence he may have once [...]
One of the things we do is help companies be really smart about their IT strategy and operations. In this business area, we like to partner with companies that see IT not as a cost centre, but as a competitive weapon. How do you use IT as a competitive weapon? There are [...]
CNN Money had some fun asking some top-tier VCs whey they’d like to invest in. Collectively, there was an imaginary $100M on the table. It makes for interesting reading - it’s not often you get a cross section of what’s at the top of a diverse set of VC minds.
I was particularly interested [...]
A couple of days, I wrote about my predictions for the return of the VC-backed drug discovery biotech technology platform company. Yesterday, there was another major acquisition of a small biotech company by a large pharmaceutical company. So, there are now several reasons why I’m expecting a flurry of VC activity in the [...]
A couple of weeks ago, we met with one of the leading venture capital groups to talk about life sciences. The purpose of the meeting was to talk about what’s really going in the hottest biotech start-ups at the moment (as with many industries, there’s so much hype around, that what is heard [...]
Imagine you’re a venture capital group that invests in both life science companies (biotechnology & pharmaceuticals) and software companies. If you’re successful in both areas, the chances are that the software side of your business is outperforming the life sciences side of your business. Which begs the question: can life science companies [...]
If you’ve followed computing in the Life Sciences, you’ll know that during the last ten years there’s been constant talk about the so-called “data explosion”. In the late 1990s, much to our amusement, barely a week would go buy without receiving some marketing letter from a vendor telling us how our data was [...]
Life Science IT has been a tough nut for IT companies to crack. They all want to do a lot better than they have historically. What is life science IT? Well, it involves such disciplines as bioinformatics, cheminformatics, chemometrics and clinical informatics, amongst many others. These subjects lie at the interface between computing [...]